(Q24246766)

https://api.crossref.org/works/10.1002%2F14651858.CD004327.PUB2

Effects of botulinum toxin on pathophysiology in spasmodic dysphonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004327.PUB2

Botulinum toxin management of spasmodic dysphonia (laryngeal dystonia): a 12-year experience in more than 900 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004327.PUB2

Outcomes assessment following treatment of spasmodic dysphonia with botulinum toxin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004327.PUB2

Increased stability of airflow following botulinum toxin injection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004327.PUB2

Electroglottographic tracking of phonatory response to Botox

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004327.PUB2

Indirect laryngoscopic approach for injection of botulinum toxin in spasmodic dysphonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004327.PUB2

Sporadic failure of botulinum toxin treatment in usually responsive patients with adductor spasmodic dysphonia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004327.PUB2

Point-touch technique of botulinum toxin injection for the treatment of spasmodic dysphonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004327.PUB2

Botulinum toxin treatment of cranial-cervical dystonia, spasmodic dysphonia, other focal dystonias and hemifacial spasm

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004327.PUB2

Effects of botulinum toxin injections on speech in adductor spasmodic dysphonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004327.PUB2

Spasmodic dysphonia: botulinum toxin injection after recurrent nerve surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004327.PUB2

Successful treatment of selected cases of abductor spasmodic dysphonia using botulinum toxin injection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004327.PUB2

Long-term therapy for spasmodic dysphonia: acoustic and aerodynamic outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004327.PUB2

A comparison of methods of botulinum toxin injection for abductory spasmodic dysphonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004327.PUB2

Resistance to botulinum toxin injections for spasmodic dysphonia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004327.PUB2

Spasmodic dysphonia: clinical features and effects of botulinum toxin therapy in 169 patients-an Australian experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004327.PUB2

The use of botulinum toxin in the treatment of adductor spasmodic dysphonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004327.PUB2

Effects of botulinum toxin therapy in patients with adductor spasmodic dysphonia: acoustic, aerodynamic, and videoendoscopic findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004327.PUB2

Botulinum toxin: basic science and clinical uses in otolaryngology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004327.PUB2

Botulinum Toxin Treatment for Spasmodic Dysphonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004327.PUB2

Outcomes of botulinum toxin treatment for patients with spasmodic dysphonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004327.PUB2

7 January 2021

Adductor laryngeal dystonia (spastic dysphonia): treatment with local injections of botulinum toxin (Botox)

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004327.PUB2

7 January 2021

A comparison of bilateral and unilateral botulinum toxin treatments for spasmodic dysphonia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004327.PUB2

7 January 2021

Treatment of cervical dystonia hand spasms and laryngeal dystonia with botulinum toxin

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004327.PUB2

7 January 2021

Effects of botulinum toxin on vocal tract steadiness in patients with spasmodic dysphonia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004327.PUB2

7 January 2021

Spastic dysphonia: a continuum disorder

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004327.PUB2

7 January 2021

Frozen versus fresh reconstituted botox for laryngeal dystonia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004327.PUB2

7 January 2021

Unilateral versus bilateral injections of botulinum toxin in patients with adductor spasmodic dysphonia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004327.PUB2

7 January 2021

A comparison of injection techniques using botulinum toxin injection for treatment of the spasmodic dysphonias

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004327.PUB2

7 January 2021

Combined-modality treatment of adductor spasmodic dysphonia with botulinum toxin and voice therapy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004327.PUB2

7 January 2021

Perceptual-acoustic relationships in spasmodic dysphonia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004327.PUB2

7 January 2021

Analysis of factors affecting botulinum toxin results in spasmodic dysphonia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004327.PUB2

7 January 2021

Adductor spasmodic dysphonia: case reports with acoustic analysis following botulinum toxin injection and acupuncture

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004327.PUB2

7 January 2021

The effect of patient factors on response outcomes to Botox treatment of spasmodic dysphonia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004327.PUB2

7 January 2021

Botox for hyperadduction of the false vocal folds: a case report

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004327.PUB2

7 January 2021

Botox treatment in adductor spasmodic dysphonia: a meta-analysis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004327.PUB2

7 January 2021

Botox Treatment in Adductor Spasmodic Dysphonia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004327.PUB2

7 January 2021

Acoustic variations in reading produced by speakers with spasmodic dysphonia pre-botox injection and within early stages of post-botox injection

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004327.PUB2

7 January 2021

Longitudinal phonatory characteristics after botulinum toxin type A injection

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004327.PUB2

7 January 2021

Adductor Muscle Activity Abnormalities in Abductor Spasmodic Dysphonia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004327.PUB2

7 January 2021

Effects of botulinum toxin type A injections on aerodynamic measures of spasmodic dysphonia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004327.PUB2

7 January 2021

Alternating unilateral botulinum toxin type A (BOTOX) injections for spasmodic dysphonia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004327.PUB2

7 January 2021

Supraglottal injection of botulinum toxin type A in adductor type spasmodic dysphonia with both intrinsic and extrinsic hyperfunction

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004327.PUB2

7 January 2021

Assessment of Posterior Cricoarytenoid Botulinum Toxin Injections in Patients with Abductor Spasmodic Dysphonia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004327.PUB2

7 January 2021

Evaluation of voice quality in adductor spasmodic dysphonia before and after botulinum toxin treatment

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004327.PUB2

7 January 2021

Electromyographic findings in focal laryngeal dystonia (spastic dysphonia)

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004327.PUB2

7 January 2021

Laryngeal dystonia: a series with botulinum toxin therapy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004327.PUB2

7 January 2021

Quantitative mapping of the effect of botulinum toxin injections in the thyroarytenoid muscle

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004327.PUB2

7 January 2021

Long-term effects of botulinum toxin injections in spasmodic dysphonia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004327.PUB2

7 January 2021

Unilateral versus bilateral botulinum toxin injections in adductor spasmodic dysphonia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004327.PUB2

7 January 2021

Assessment: the clinical usefulness of botulinum toxin-A in treating neurologic disorders. Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004327.PUB2

7 January 2021

Localized injections of botulinum toxin for the treatment of focal laryngeal dystonia (spastic dysphonia)

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004327.PUB2

7 January 2021

Abductor laryngeal dystonia: a series treated with botulinum toxin

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004327.PUB2

7 January 2021

[Use of botulinum toxin in the treatment of laryngeal dystonia (spasmodic dysphonia): preliminary study of twelve patients]

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004327.PUB2

7 January 2021